Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Clements

Showing results (331-340 of 462) with videos related to

Pageof 47
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 30, 1998
Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein DC Botas, F Poulain, J Akiyama, et al.
Rheumatology (Oxford, England)|October 2, 2010
Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosisVijay Bodukam, Ron D Hays, Paul Maranian, et al.
Angewandte Chemie (International Ed. in English)|August 12, 2005
The design and evaluation of heparin-binding foldamersSungwook Choi, Dylan J Clements, Vojislava Pophristic, et al.
Case Reports in Rheumatology|November 8, 2014
Acute hemorrhagic myositis in inflammatory myopathy and review of the literatureHoward Van Gelder, Kim M Wu, Nayiri Gharibian, et al.
Bioorganic & Medicinal Chemistry|September 19, 2012
Identification and development of the 1,4-benzodiazepin-2-one and quinazoline-2,4-dione scaffolds as submicromolar inhibitors of HATRachel L Clark, Carol J Clements, Michael P Barrett, et al.
ACR Open Rheumatology|May 21, 2020
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study IIElizabeth R Volkmann, Donald P Tashkin, Holly LeClair, et al.
British Journal of Cancer|January 20, 2006
COSMIC 2005S Forbes, J Clements, E Dawson, et al.
Current Protocols in Human Genetics|April 23, 2008
The Catalogue of Somatic Mutations in Cancer (COSMIC)S A Forbes, G Bhamra, S Bamford, et al.
Arthritis and Rheumatism|July 20, 2011
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung diseaseDinesh Khanna, Rajeev Saggar, Maureen D Mayes, et al.
The Journal of Rheumatology|February 17, 2007
Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosisVanessa L Malcarne, Ingunn Hansdottir, Ann McKinney, et al.
Pageof 47

Showing results (331-340 of 462) with videos related to

Sort By:
Pageof 47
Proceedings of the National Academy of Sciences of the United States of America|September 30, 1998
Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein DC Botas, F Poulain, J Akiyama, et al.
Rheumatology (Oxford, England)|October 2, 2010
Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosisVijay Bodukam, Ron D Hays, Paul Maranian, et al.
Angewandte Chemie (International Ed. in English)|August 12, 2005
The design and evaluation of heparin-binding foldamersSungwook Choi, Dylan J Clements, Vojislava Pophristic, et al.
Case Reports in Rheumatology|November 8, 2014
Acute hemorrhagic myositis in inflammatory myopathy and review of the literatureHoward Van Gelder, Kim M Wu, Nayiri Gharibian, et al.
Bioorganic & Medicinal Chemistry|September 19, 2012
Identification and development of the 1,4-benzodiazepin-2-one and quinazoline-2,4-dione scaffolds as submicromolar inhibitors of HATRachel L Clark, Carol J Clements, Michael P Barrett, et al.
ACR Open Rheumatology|May 21, 2020
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study IIElizabeth R Volkmann, Donald P Tashkin, Holly LeClair, et al.
British Journal of Cancer|January 20, 2006
COSMIC 2005S Forbes, J Clements, E Dawson, et al.
Current Protocols in Human Genetics|April 23, 2008
The Catalogue of Somatic Mutations in Cancer (COSMIC)S A Forbes, G Bhamra, S Bamford, et al.
Arthritis and Rheumatism|July 20, 2011
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung diseaseDinesh Khanna, Rajeev Saggar, Maureen D Mayes, et al.
The Journal of Rheumatology|February 17, 2007
Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosisVanessa L Malcarne, Ingunn Hansdottir, Ann McKinney, et al.
Pageof 47